← Back to headlines
Johnson & Johnson Leverages AI to Accelerate Drug Development
Johnson & Johnson is utilizing artificial intelligence to significantly reduce the time required to identify promising chemical compounds and biologics for drug development, according to CIO Jim Swanson.
28 Apr, 04:16 — 28 Apr, 04:16
Related Stories
New African Swine Fever Case Confirmed in Southeast Finland
1h ago
Luigi Mangione Pleads Guilty to Killing UnitedHealthcare CEO Brian Thompson
1h ago
Maharashtra FDA Suspends Licenses of Blinkit, Zepto, Instamart Hubs Over Hygiene Violations
1h ago
Toxic Gas Leak Kills Eight at Bangladesh Shipbreaking Yard, Five Missing
1h ago